David S. Johnson, PhD, MBA
Chief Executive Officer and Co-Founder
Dr. Johnson is an inventor, entrepreneur, and expert in single-cell genomics with a track record of bringing new medical technologies to market. Dr. Johnson was among the founding members and COO of Natera, a Silicon Valley genetics startup funded by Sequoia Capital and other top-tier venture capitalists. At Natera, Dr. Johnson was responsible for all clinical operations, laboratory research, clinical studies, and clinical product development. He was directly responsible for invention and commercialization of two genomic products for preimplantation genetic diagnosis (PGD), which captured >30% market share less than a year after commercial launch. Prior to Natera he was the ENCODE Project Director at the Stanford Human Genome Center. Dr. Johnson holds a BS in Biology from Duke University, a PhD in Genetics from Stanford University, and an MBA from the Haas School of Business at the University of California, Berkeley.